Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 15 min 49 sec ago

Heat Biologics, Inc. Appoints Taylor H. Schreiber, M.D., PH.D. as Vice President of Research and Development

Wed, 03/05/2014 - 19:37
Dr. Schreiber's Expertise in Heat Shock Protein Oncology Immunotherapy Strengthens the Company's Commitment to Identifying and Developing New ImPACT Therapy Vaccine Targets to Combat a Variety of Cancers CHAPEL HILL, NC--(Healthcare Sales & Marketing Ne...
Biopharmaceuticals, Oncology, Personnel
Heat Biologics, ImPACT Therapy, immunotherapy

Leading Cancer Center in Portugal Becomes First in World to Offer Edge(TM) Radiosurgery

Wed, 03/05/2014 - 16:24
Lung, Prostate, and Brain Cancer Patients Receive Edge Radiosurgery at Champalimaud Center for the Unknown LISBON, Portugal, March 5, 2014 -- (Healthcare Sales & Marketing Network) -- Doctors at the Champalimaud Center for the Unknown here have perform...
Devices, Oncology
Varian Medical Systems, Edge radiosurgery, radiosurgery, radiotherapy

Revance to Add Angus C. Russell as Chairman to Its Board of Directors

Wed, 03/05/2014 - 16:21
NEWARK, Calif., March 5, 2014 -- (Healthcare Sales & Marketing Network) -- Revance Therapeutics, Inc. (RVNC), a specialty biopharmaceutical company which develops botulinum toxin products for use in aesthetic and therapeutic indications, today announced th...
Biopharmaceuticals, Personnel
Revance Therapeutics, TransMTS, botulinum

Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer

Wed, 03/05/2014 - 16:19
DEEFIELD, IL--(Healthcare Sales & Marketing Network) - Horizon Pharma, Inc. (NASDAQ: HZNP) today announced the appointment of Robert F. Carey as executive vice president and chief business officer, bringing a broad base of healthcare investment banking ex...
Biopharmaceuticals, Personnel

Caliber Imaging and Diagnostics Names Robert T. Kelley to Vice President of U.S. Sales

Wed, 03/05/2014 - 12:24
BOSTON and ROCHESTER, N.Y., March 5, 2014 -- (Healthcare Sales & Marketing Network) -- Caliber Imaging & Diagnostics (LCDX), formerly Lucid, Inc., has named Robert T. Kelley to Vice President of U.S. Sales, effective immediately. Mr. Kelley had served as C...
Devices, Radiology, Personnel
Caliber Imaging & Diagnostics, VivaScope

Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma

Wed, 03/05/2014 - 11:58
First Phase III study of daratumumab Patient recruitment to start in the coming months COPENHAGEN, Denmark, March 5, 2014 -- (Healthcare Sales & Marketing Network) -- Genmab A/S (GEN.CO) announced today that its partner, Janssen Biotech, Inc. ("...
Biopharmaceuticals, Oncology
Genmab, Janssen Biotech, daratumumab, multiple myeloma

Hospira Names David J. Endicott President of Medical Devices

Tue, 03/04/2014 - 16:34
Endicott brings extensive industry experience and vision to advance company's device strategy and drive global growth LAKE FOREST, Ill., March 4, 2014 -- (Healthcare Sales & Marketing Network) -- Hospira, Inc. (HSP), the world's leading provider of inj...
Devices, Personnel

Teva Announces Approval of Generic Evista(R) Tablets 60 mg in the United States

Tue, 03/04/2014 - 16:31
JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd. (TEVA) announces the approval of the generic equivalent to Evista® (Raloxifene) Tablets, 60 mg, in the United States. Teva was first to file, making the product elig...
Biopharmaceuticals, Generics, FDA, Product Launch
Teva Pharmaceutical, Evista, Raloxifene

SharedClarity Awards First Contracts

Tue, 03/04/2014 - 16:29
Medtronic, Abbott to Provide Bare Metal and Drug-Eluting Stents PHOENIX--(Healthcare Sales & Marketing Network)--SharedClarity announced today its first contract awards, with Medtronic and Abbott chosen to provide bare metal and drug-eluting stents to S...
Devices, Interventional Cardiology, Group Purchasing
SharedClarity, Medtronic, Abbott, drug-eluting stent

Contextual Genomics Appoints Chris Wagner as President and CEO

Tue, 03/04/2014 - 16:26
VANCOUVER, British Columbia--(Healthcare Sales & Marketing Network)--Contextual Genomics, a next generation molecular diagnostics company, announced today that Chris Wagner has been appointed President and Chief Executive Officer. “We are very pleased t...
Diagnostics, Oncology, Cardiology, Personnel
Contextual Genomics

Pernix Therapeutics Appoints Vice President of Compliance

Tue, 03/04/2014 - 13:06
HOUSTON--(Healthcare Sales & Marketing Network)--Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, today announced the appointment of Jessica Oien as Vice President of Compliance. “As we continue to focus on growing our busin...
Biopharmaceuticals, Personnel
Pernix Therapeutics Holdings

Atossa Genetics Inc. Announces FDA Response to 510(k) Submission for ForeCYTE Breast Aspirator

Tue, 03/04/2014 - 13:04
SEATTLE, WA--(Healthcare Sales & Marketing Network) - Atossa Genetics Inc. (NASDAQ: ATOS) announced today that it has received a request for additional information from the U.S. Food and Drug Administration (FDA) related to its 510(k) application for the F...
Devices, Diagnostics, Oncology, FDA
Atossa Genetics, ForeCYTE, Breast Aspirator

Neos Therapeutics Completes $15.5 Million Additional Series C Financing

Tue, 03/04/2014 - 12:56
DALLAS/FORT WORTH, Texas--(Healthcare Sales & Marketing Network)--Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of inno...
Biopharmaceuticals, Drug Delivery, Venture Capital
Neos Therapeutics

Cell Migration Enhanced with Procellera(R) Wireless Microcurrent Generating Wound Dressing

Tue, 03/04/2014 - 12:40
Groundbreaking Study Published in PLOS ONE Unveils Substantial Potential of Bioelectriceuticals in Wound Care and Beyond TEMPE, Ariz., March 4, 2014 -- (Healthcare Sales & Marketing Network) -- Procellera® – the world's first wireless microcurrent ...
Devices, Wound Care
Vomaris Wound Care, Procellera, microcell batteries, wound dressing

Invuity(R) Raises $36 Million in Series E Financing

Tue, 03/04/2014 - 12:34
SAN FRANCISCO--(Healthcare Sales & Marketing Network)--Invuity, Inc., a developer of advanced medical devices to dramatically improve access and visualization in minimally invasive and minimal access surgeries, announced today that it has secured $36 milli...
Devices, Surgery, Venture Capital
Invuity, Eigr

ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US

Tue, 03/04/2014 - 12:28
Ocriplasmin Research to Better Inform Treatment (ORBIT) study designed to generate further data on the "real world" use of JETREA® LEUVEN, Belgium, March 4, 2014 -- (Healthcare Sales & Marketing Network) --ThromboGenics NV (Euronext Bruss...
Biopharmaceuticals, Ophthalmology
ThromboGenics, Ocriplasmin, JETREA, vitreomacular adhesion

Visian(R) ICL(TM) with CentraFLOW(R) Approved to Market in Japan

Mon, 03/03/2014 - 21:52
Over 50,000 ICLs Successfully Implanted with CentraFLOW Driven by the KS-AquaPORT Technology™ MONROVIA, Calif., March 3, 2014 -- (Healthcare Sales & Marketing Network) -- STAAR Surgical Company (STAA), a leading developer, manufacturer and marketer of ...
Devices, Ophthalmology, Regulatory
STAAR Surgical, Visian, Implantable Collamer Lens, CentraFLOW

BioRestorative Therapies Names Gregory Lutz, M.D. as Chief Medical Advisor for Spine Medicine

Mon, 03/03/2014 - 21:47
Dr. Lutz, Physiatrist-in-Chief Emeritus for the Hospital for Special Surgery, assumes responsibility for clinical aspects of the brtxDISC™ Program JUPITER, Fla.--(Healthcare Sales & Marketing Network)--BioRestorative Therapies, Inc. ("BRT" or ...
Regenerative Medicine, Personnel
BioRestorative Therapies

Vansen Pharma Inc. appoints new President and CEO

Mon, 03/03/2014 - 21:42
LAS VEGAS, March 3, 2014 -- (Healthcare Sales & Marketing Network) - Vansen Pharma Inc. [OTCQB: VNSN], a specialty pharmaceutical company, is pleased to announce the appointment of Dr. Ahmad Doroudian as its President and Chief Executive Officer. Dr. Doro...
Biopharmaceuticals, Personnel
Vansen Pharma

PaxVax Announces New Commercial Senior Leadership Appointments

Mon, 03/03/2014 - 15:31
New Hires Expand Senior Management Team Ahead of Anticipated Cholera Vaccine Launch MENLO PARK, Calif. & SAN DIEGO--(Healthcare Sales & Marketing Network)--PaxVax Inc., a specialty vaccine company focused on travelers and biodefense markets with a socia...
Biopharmaceuticals, Personnel
PaxVax, vaccine

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong